Author: Admin Admin
-
Invention for Combination of ABCG2 Inhibitors with Sacituzumab Govitecan (IMMU-132) Overcomes Resistance to SN-38 for Trop-2 expressing Cancers
Invented by Chien-Hsing Chang, David M. Goldenberg, Immunomedics Inc cancers. The market for combination therapies in cancer treatment is constantly evolving, with researchers and pharmaceutical companies striving to find new ways to overcome resistance and improve patient outcomes. One promising combination that has shown great potential is the use of ABCG2 inhibitors in conjunction with…
-
Invention for Bispecific antibodies that bind to CD38 andCD3
Invented by Matthew Bernett, Seung Chu, Gregory Moore, John Desjarlais, Xencor Inc The market for bispecific antibodies that bind to CD38 and CD3 is rapidly growing, thanks to their potential in treating various types of cancer. CD38 is a cell surface protein that is highly expressed on multiple myeloma cells, while CD3 is a protein…
-
Invention for Inhalable Dry Powders
Invented by Wesley H. Dehaan, Jean C. Sung, Diana Manzanedo, Ciaran Lawlor, Michael Tauber, Pulmatrix Operating Co Inc The market for inhalable dry powders has been steadily growing in recent years, driven by advancements in technology and a growing demand for convenient and effective respiratory treatments. Inhalable dry powders offer a non-invasive and user-friendly alternative…
-
Invention for Anti-HER2 antibodies, compositions and formulations
Invented by Mikkel Wandahl Pedersen, Allan Jensen, Per-Johan Meijer, Symphogen AS The market for Anti-HER2 antibodies, compositions, and formulations has been experiencing significant growth in recent years. HER2 (Human Epidermal Growth Factor Receptor 2) is a protein that is overexpressed in certain types of cancer, including breast and gastric cancer. Anti-HER2 antibodies are designed to…
-
Invention for Tyrosine Bioconjugation Through Aqueous Ene-Like Reactions
Invented by Carlos F. Barbas, III, Hitoshi Ban, Julia Gavrilyuk, Scripps Research Institute The market for tyrosine bioconjugation through aqueous ene-like reactions is experiencing significant growth and is poised to expand even further in the coming years. This emerging field of bioconjugation offers numerous opportunities for researchers and companies in the pharmaceutical, biotechnology, and diagnostic…
-
Invention for Trispecific antagonists
Invented by Jackie SHENG, Bo Liu, Gensun Biopharma Inc The market for trispecific antagonists is rapidly expanding, driven by the increasing demand for innovative therapeutic options in various disease areas. Trispecific antagonists are a type of biologic drug that target multiple disease pathways simultaneously, offering the potential for enhanced efficacy and improved patient outcomes. Trispecific…
-
Invention for Immunogenic Compositions containing Mycobacterium Tuberculosis Polypeptides
Invented by Steven G. Reed, Rhea N. Coler, Gregory C. Ireton, Sylvie Bertholet, Access to Advanced Health Institute AAHI The market for immunogenic compositions containing Mycobacterium tuberculosis polypeptides is expected to witness significant growth in the coming years. Mycobacterium tuberculosis (MTB) is the bacterium responsible for causing tuberculosis (TB), a highly infectious disease that primarily…
-
Invention for Cyclodextrin based polymers
Invented by Jianjun Cheng, Mark E. Davis, Kay T. Khin, Novartis AG The market for cyclodextrin-based polymers has been steadily growing in recent years, driven by their wide range of applications in various industries. These unique polymers, derived from cyclodextrins, offer exceptional properties that make them highly sought after in sectors such as pharmaceuticals, food…
-
Invention for Antibody Fc Mutants with Ablated Effector Functions
Invented by McCarthy Stephen, Bernard Scallon, William Strohl, Susan Tam, Omid Vafa, Janssen Biotech Inc The market for Antibody Fc Mutants with Ablated Effector Functions is witnessing significant growth in recent years. Antibodies are an essential component of the immune system and play a crucial role in fighting against various diseases. However, the effector functions…
-
Invention for Crystal Forms of?-nicotinamide Mononucleotide
Invented by David J. Livingston, Andrew Carr, Philippe Fernandes, Metrobiotech LLC, Metro International Biotech LLC The market for Crystal Forms of Nicotinamide Mononucleotide (NMN) Nicotinamide Mononucleotide (NMN) is a compound that has gained significant attention in recent years due to its potential anti-aging properties. As a precursor to nicotinamide adenine dinucleotide (NAD+), NMN has been…